Haegarda 2000 IU lyophilized powder for injection Images
Generic Name: C1 esterase inhibitor (human)
This medication has been identified as Haegarda 2000 IU lyophilized powder for injection. It is supplied by CSL Behring.
Haegarda is used in the treatment of Hereditary Angioedema and belongs to the drug class hereditary angioedema agents. Risk cannot be ruled out during pregnancy. Haegarda 2000 IU lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Haegarda
- Generic Name
- C1 esterase inhibitor (human)
- Strength
- 2000 IU lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Hereditary angioedema agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- CSL Behring
- National Drug Code (NDC)
- 63833-0828
More about Haegarda (C1 esterase inhibitor (human))
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: hereditary angioedema agents
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
